PLEASANTON, CALIF., September 30, 2016 — CooperVision has unveiled PrescribeOyxgen.com, a new website that provides eye care professionals with details about the benefits of contact lenses with high oxygen transmissibility.
“CooperVision’s partnership with eye care professionals around the world is leading the more rapid adoption of 1-day silicone hydrogel contact lenses,” said Michelle North, Marketing Director. “PrescribeOxygen.com will help educate eye care professionals not only about our portfolio of silicone hydrogel 1-day contact lenses, but the data that supports prescribing patients with a healthier 1-day lens-wearing experience.”
Research shows that U.S. 1-day wearers habitually wear their lenses for at least 15 hours per day and 7 days per week.1 In addition, the research also shows that 75% of contact lens wearers report napping while wearing their contact lenses at least once in the last month.1*
With CooperVision’s portfolio of silicone hydrogel 1-day contact lenses, eye care professionals can fit virtually all patients into a 1-day contact lens that provides high oxygen, comfort and convenience.
“Two of my favorite lenses are MyDay® and clariti® 1 day,” said Dr. Ami Ranani, OD, Somers Eye Center, Somers, N.Y. “ My patients really love the comfort of MyDay® and I generally fit it on those not happy with their existing 1-day lenses. I recommend clariti® 1 day for new wearers or existing hydrogel 1-day wearers who need the extra oxygen, but won’t pay a premium price. clariti® 1 day is also my go-to for my 2-week and monthly patients switching to 1-day lenses.”
For more information, please visit CooperVision.com.
1Dumbleton K. et al (2013) A multi-country assessment of compliance with daily disposable contact lens wear; Contact Lens & Anterior Eye 36 304-312.
* It is essential that patients follow eye care practitioner’s directions and all labeling instructions for proper use of lenses.
# # #
About CooperVision
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has approximately 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact:
Mike McDougall, McDougall Communications for CooperVision, Inc.
mike@mcdougallpr.com or +1-585-545-1815 (mobile)